Skip to content
Insider tapeFilings through Fri, Nov 20
My stocks

Nancy C. Andrews

At a glance: Nancy C. Andrews is Director at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Aug 20, 2026, reported a sale of $163K. On file: 0 purchase lines ($0) and 1 sale line ($163K).

Disclosed holdings: about $452K of CRL stock: 1,438 shares reported on their latest Form 4 (filed Aug 20, 2026), valued at the Nov 20, 2026 close of $314.32. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Charles River Laboratories International, Inc. (CRL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $163K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC CRLCharles River Laboratories International, Inc. Sell 5731,438 held (−28%) $285.24 $163K +10.2%
  • Sell

    Director Nancy C Andrews sold $163K of CRL at $285.24 — cuts the stake by 28%.

Follow Nancy C. Andrews

Get one email when Nancy C. Andrews files a new purchase or sale. Free.

At most one email a day about Nancy C. Andrews, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.